As filed with the Securities and Exchange Commission on December 22, 2005.
Registration No. 333-__________
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------------------
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
---------------------------------
NEOPROBE CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware 31-1080091
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No.)
425 Metro Place North, Suite 300
Dublin, Ohio 43017
(Address of Registrant's principal executive offices)
---------------------------------
NEOPROBE CORPORATION 401(k) PLAN
(Full Title of the Plan)
---------------------------------
Brent L. Larson
Vice President, Finance, Chief Financial Officer,
Treasurer and Secretary
Neoprobe Corporation
425 Metro Place North, Suite 300
Dublin, Ohio 43017
(614) 793-7500
(Name, address and telephone number of agent for service)
---------------------------------
Copies of Correspondence to:
William J. Kelly, Jr., Esq.
Porter, Wright, Morris & Arthur LLP
41 South High Street
Columbus, Ohio 43215
(614) 227-2136
wjkelly@porterwright.com
---------------------------------
Calculation of Registration Fee
--------------------------------------------------------------------------------------------------------------
Proposed Maximum Proposed Maximum
Title of Securities Amount to be Offering Price Aggregate Offering Amount of
to be Registered* Registered** Per Share*** Price*** Registration Fee
--------------------------------------------------------------------------------------------------------------
Common Stock,
$.001 par value 400,000 $0.25 $100,000 $10.70
--------------------------------------------------------------------------------------------------------------
*This Registration Statement covers only shares of common stock, $.001 par
value, of Neoprobe Corporation ("Neoprobe Common Stock") that may be issued to
the Neoprobe Corporation 401(k) Plan (the "Plan") or its beneficiaries as
employer matching contributions. The interests of employees in the Plan are not
being registered hereby.
**The number of shares being registered is based upon an estimate of the number
of shares of Neoprobe Common Stock that will be issued to the Plan and its
beneficiaries as matching contributions under the Plan. This Registration
Statement shall be deemed to cover an indeterminate number of additional shares
of Neoprobe Common Stock, as may be issuable pursuant to future stock dividends,
stock splits or similar transactions.
***Estimated solely for the purpose of calculating the proposed maximum
aggregate offering price and the registration fee pursuant to Rule 457(h) under
the Securities Act of 1933, based upon the average of the high and low prices of
Neoprobe Common Stock as reported on the Over-The-Counter Bulletin Board on
December 16, 2005.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
The information called for in Part I of Form S-8 is not being filed
with or included in this Registration Statement (by incorporation by reference
or otherwise) in accordance with the Note to Part I of Form S-8, but will be
sent or given to participants as specified by Rule 428(b)(1).
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference
Neoprobe Corporation ("Neoprobe" or the "Company") incorporates by
reference the following documents that the Company has previously filed with the
Securities and Exchange Commission:
1. Annual Report on Form 10-KSB for the fiscal year ended
December 31, 2004, filed March 31, 2005.
2. Quarterly Report on Form 10-QSB for the quarter ended March
31, 2005 (filed May 16, 2005); Quarterly Report on Form 10-QSB
for the quarter ended June 30, 2005 (filed August 15, 2005);
and Quarterly Report on Form 10-QSB for the quarter ended
September 30, 2005 (filed November 14, 2005).
3. Current Report on Form 8-K dated January 3, 2005 (filed
January 5, 2005); Current Report on Form 8-K dated January 18,
2005 (filed January 21, 2005); Current Report on Form 8-K (as
to Item 8.01 and Exhibit 99.2 to Item 9.01 only) dated
February 24, 2005 (filed February 28, 2005); Current Report on
Form 8-K (as to Item 8.01 and Exhibit 99.2 to Item 9.01 only)
dated April 26, 2005 (filed May 3, 2005); and Current Report
on Form 8-K dated September 27, 2005 (filed September 30,
2005).
4. Notice of Annual Meeting and Proxy Statement, filed April 29,
2005.
5. The description of Neoprobe common stock which is contained in
Neoprobe's Form 8-A filed with the Securities and Exchange
Commission pursuant to Section 12 of the Securities Exchange
Act of 1934, as amended, as updated in any amendment or report
filed for the purpose of updating such description, is hereby
incorporated by reference.
All documents filed by Neoprobe pursuant to Sections 13(a), 13(c), 14
or 15(d) of the Securities Exchange Act of 1934, as amended, after the date of
this Registration Statement and prior to the filing of a post-effective
amendment which indicates that all securities offered hereunder have been sold
or which deregisters all securities then remaining unsold, shall be deemed to be
incorporated by reference in this Registration Statement and to be a part hereof
from the date of filing of such documents. Any statement incorporated by
reference herein shall be deemed to be modified or superseded for purposes of
this Registration Statement to the extent that a statement contained herein or
in any other subsequently filed document which also is or is deemed to be
incorporated by reference herein modifies or supersedes such statement. Any
statement so modified or superseded shall not be deemed, except as so modified
or superseded, to constitute a part of this Registration Statement.
Item 4. Description of Securities
Not applicable.
Item 5. Interests of Named Experts and Counsel
Not applicable.
II-1
Item 6. Indemnification of Directors and Officers
Section 145 of the General Corporation Law of the State of Delaware
(Section 145) provides that directors and officers of Delaware corporations may,
under certain circumstances, be indemnified against expenses (including
attorneys' fees) and other liabilities actually and reasonably incurred by them
as a result of any suit brought against them in their capacity as a director or
officer, if they acted in good faith and in a manner they reasonably believed to
be in or not opposed to the best interests of the corporation, and, with respect
to any criminal action or proceeding, if they had no reasonable cause to believe
their conduct was unlawful. Section 145 also provides that directors and
officers may also be indemnified against expenses (including attorneys' fees)
incurred by them in connection with a derivative suit if they acted in good
faith and in a manner they reasonably believed to be in or not opposed to the
best interests of the corporation, except that no indemnification may be made
without court approval if such person was adjudged liable to the corporation.
Article V of the Company's By-laws contains provisions which require
that the Company indemnify its officers, directors, employees and agents, in
substantially the same language as Section 145.
Article Nine, section (b), of the Company's Certificate of
Incorporation further provides that no director will be personally liable to the
Company or its stockholders for monetary damages or for any breach of fiduciary
duty except for breach of the director's duty of loyalty to the Company or its
stockholders, for acts or omissions not in good faith or involving intentional
misconduct or a knowing violation of law, pursuant to Section 174 of the
Delaware General Corporation Law (which imposes liability in connection with the
payment of certain unlawful dividends, stock purchases or redemptions), or any
amendment or successor provision thereto, or for any transaction from which a
director derived an improper personal benefit.
Item 7. Exemption from Registration
Not applicable.
II-2
Item 8. Exhibits
Exhibit Number Description
4(a) * Neoprobe Corporation 401(k) Plan.
4(b) Restated Certificate of Incorporation of
Neoprobe Corporation as corrected February
18, 1994, and amended June 27, 1994, June 3,
1996, March 17, 1999, May 9, 2000, June 13,
2003, July 27, 2004, and June 22, 2005
(previously filed as Exhibit 3.1 to the
Company's Quarterly Report on Form 10-QSB,
filed with the Securities and Exchange
Commission on August 15, 2005, and
incorporated herein by reference).
4(c) Amended and Restated By-laws dated July 21,
1993, as amended July 18, 1995, and May 30,
1996 (previously filed as Exhibit 99.4 to
the Company's Current Report on Form 8-K,
filed with the Securities and Exchange
Commission on June 19, 1996, and
incorporated herein by reference).
5(a) * Opinion of Porter, Wright, Morris & Arthur LLP
regarding legality.
5(b) * Determination letter dated November 21, 2005,
confirming that the Neoprobe Corporation 401(k)
Plan is qualified under section 401 of the
Internal Revenue Code of 1986, as amended.
23(a) Consent of Porter, Wright, Morris & Arthur LLP
(included in Exhibit 5 filed herewith).
23(b) * Consent of Independent Registered Public
Accounting Firm.
24 * Powers of Attorney.
----------------
* Filed herewith.
Item 9. Undertakings
The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement
to include any material information with respect to the plan of
distribution not previously disclosed in the registration
statement or any material change to such information in the
registration statement.
(2) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post- effective amendment shall
be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering
thereof.
(3) To remove from registration by means of a post-effective
amendment any of the securities being registered which remain
unsold at the termination of the offering.
The undersigned Registrant hereby undertakes that, for purposes of
determining any liability under the Securities Act of 1933, each filing of the
Registrant's annual report pursuant to Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit
plan's annual report pursuant to Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration statement shall be
deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the Registrant pursuant to the foregoing provisions, or otherwise, the
Registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.
II-3
Signatures
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements of filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Dublin, State of Ohio, on December 22, 2005.
NEOPROBE CORPORATION
/s/ Brent L. Larson
------------------------------------------------
Brent L. Larson, Vice President, Finance, Chief
Financial Officer, Treasurer and Secretary
Pursuant to the requirements of the Securities Act of 1933, as amended,
this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:
Signature Title Date
* David C. Bupp President, Chief Executive Officer December 22, 2005
--------------------------- and Director
David C. Bupp (principal executive officer)
/s/ Brent L. Larson Vice President, Finance, Chief December 22, 2005
--------------------------- Financial Officer, Treasurer and
Brent L. Larson Secretary (principal financial officer
and principal accounting officer)
* Carl J. Aschinger, Jr. Director December 22, 2005
---------------------------
Carl J. Aschinger, Jr.
* Reuven Avital Director December 22, 2005
---------------------------
Reuven Avital
* Kirby I. Bland Director December 22, 2005
---------------------------
Kirby I. Bland
* Julius R. Krevans Chairman of the Board of December 22, 2005
--------------------------- Directors
Julius R. Krevans
* Fred B. Miller Director December 22, 2005
---------------------------
Fred B. Miller
* J. Frank Whitley, Jr. Director December 22, 2005
---------------------------
J. Frank Whitley, Jr.
* By: /s/ Brent L. Larson
---------------------------------------------
Brent L. Larson, attorney-in-fact for each
of the persons indicated
II-4
Registration No. 333-______________
--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
------------------------------
NEOPROBE CORPORATION
------------------------------
EXHIBITS
------------------------------
EXHIBIT INDEX
Exhibit Exhibit
Number Description
------ -----------
4(a) * Neoprobe Corporation 401(k) Plan.
4(b) Restated Certificate of Incorporation of Neoprobe Corporation
as corrected February 18, 1994, and amended June 27, 1994,
June 3, 1996, March 17, 1999, May 9, 2000, June 13, 2003, July
27, 2004, and June 22, 2005 (previously filed as Exhibit 3.1
to the Company's Quarterly Report on Form 10-QSB, filed with
the Securities and Exchange Commission on August 15, 2005, and
incorporated herein by reference).
4(c) Amended and Restated By-laws dated July 21, 1993, as amended
July 18, 1995, and May 30, 1996 (previously filed as Exhibit
99.4 to the Company's Current Report on Form 8-K, filed with
the Securities and Exchange Commission on June 19, 1996, and
incorporated herein by reference).
5(a) * Opinion of Porter, Wright, Morris & Arthur LLP regarding
legality.
5(b) * Determination letter dated November 21, 2005, confirming
that the Neoprobe Corporation 401(k) Plan is qualified under
section 401 of the Internal Revenue Code of 1986, as amended.
23(a) Consent of Porter, Wright, Morris & Arthur LLP (included in
Exhibit 5 filed herewith).
23(b) * Consent of Independent Registered Public Accounting Firm.
24 * Powers of Attorney.
----------------
* Filed herewith.